16 May 2024
Drug-coated balloons in de novo coronary artery disease
With the collaboration of the Vietnam National Heart Association, Philippine Society of Cardiovascular Catheterisation and Interventions and Cardiac Society Brunei Darussalam
Summary
This session, in collaboration with various cardiology societies, focuses on the use of drug-coated balloons (DCBs) in the treatment of de novo coronary artery disease. It covers the optimal technique for PCI with DCBs, the indications and use of DCBs in small vessels, bifurcations, and multivessel disease, as well as the role of DCBs in different clinical settings, including acute coronary syndrome and high bleeding risk patients.
Learning Objectives
- To understand the optimal technique for PCI with drug-coated balloon
- To explore the indications and use of drug-coated balloons balloons in small vessels, bifurcations and multivessel disease
- To discuss the role of drug-coated balloons in different clinical settings including ACS and in high bleeding risk
